In conclusion, after a comprehensive clinical examination and high-throughput genetic testing, we diagnosed three novel missense mutations in ACP5 and SAMHD1 in a patient with refractory SLE. This evidence concerns the gene SAMHD1 and systemic lupus erythematosus.